- Home
- ITT vs NBIX Comparison
ITT vs NBIX Comparison
Compare ITT & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITT | NBIX |
|---|---|---|
| Founded | 1920 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0B | 13.9B |
| IPO Year | 1994 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ITT | NBIX |
|---|---|---|
| Price | $197.37 | $134.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 22 |
| Target Price | ★ $215.33 | $175.23 |
| AVG Volume (30 Days) | 965.3K | ★ 1.2M |
| Earning Date | 06-01-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.80% | N/A |
| EPS Growth | N/A | ★ 41.95 |
| EPS | ★ 6.11 | 4.67 |
| Revenue | ★ $3,938,500,000.00 | $161,626,000.00 |
| Revenue This Year | $7.48 | $22.85 |
| Revenue Next Year | $5.50 | $9.99 |
| P/E Ratio | $31.54 | ★ $28.20 |
| Revenue Growth | 8.48 | ★ 977.51 |
| 52 Week Low | $105.64 | $84.23 |
| 52 Week High | $209.70 | $160.18 |
Technical Indicators
Market Signals| Indicator | ITT | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 50.46 | 52.70 |
| Support Level | $168.77 | $133.96 |
| Resistance Level | $207.98 | $137.37 |
| Average True Range (ATR) | 5.81 | 3.92 |
| MACD | -1.71 | 0.65 |
| Stochastic Oscillator | 46.74 | 96.34 |
Price Performance
Historical ComparisonAbout ITT ITT Inc.
ITT began its journey as International Telephone & Telegraph in 1920. Through decades of acquisitions in the mid-1900s, ITT went from manufacturing telephone switching equipment to operating hotels, car rentals, insurance agencies, and bread bakeries. In 1995, the firm split into three separate entities, one of which is the ITT in current operation. After a few more spinoffs in 2011, today ITT Inc. sells automotive, industrial, and aerospace products such as brake pads, seals, pumps, valves, connectors, and regulators. It has operations around the globe with notable exposures to North America, Europe, and Asia.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.